logo

Applied Genetic Technologies Corp. (AGTC)



Trade AGTC now with
  Date
  Headline
1/23/2020 7:18:24 AM Applied Genetic Reports Encouraging Data From Phase I/II Studies Of Its Gene Therapy Candidate For Achromatopsia
1/9/2020 7:05:00 AM Applied Genetic Reports Positive 6-Month Data From Phase 1/2 Clinical Trial In X-Linked Retinitis Pigmentosa
10/1/2019 7:39:20 AM Applied Genetic Technologies, Otonomy Enter Strategic Collaboration
9/26/2019 4:08:07 PM Applied Genetic Technologies Q4 Loss/share $0.58 Vs. Loss $0.36 Year Ago
5/8/2019 9:24:37 AM Wedbush Is Increasing Applied Genetic Technologies Corp. (AGTC) FY20 Estimate To -1.51 From -2.18
5/8/2019 9:24:12 AM Wedbush Is Increasing Applied Genetic Technologies Corp. (AGTC) Q4 20 Estimate To -0.35 From -0.50
5/8/2019 9:23:49 AM Wedbush Is Increasing Applied Genetic Technologies Corp. (AGTC) Q3 20 Estimate To -0.34 From -0.49
5/8/2019 9:23:36 AM Wedbush Is Increasing Applied Genetic Technologies Corp. (AGTC) Q2 20 Estimate To -0.42 From -0.60
5/8/2019 9:23:23 AM Wedbush Is Increasing Applied Genetic Technologies Corp. (AGTC) Q1 20 Estimate To -0.41 From -0.59
5/8/2019 9:23:07 AM Wedbush Is Raising Applied Genetic Technologies Corp. (AGTC) FY19 Estimate To 0.07 From -1.81
5/8/2019 9:22:52 AM Wedbush Is Raising Applied Genetic Technologies Corp. (AGTC) Q4 19 Estimate To -0.40 From -0.58
5/8/2019 9:22:22 AM Wedbush Reiterates Applied Genetic Technologies Corp. (AGTC) At Outperform With $11 Price Target
4/8/2019 7:09:18 AM Applied Genetic Reports Enrollment Milestones In Two Phase 1/2 Clinical Trials
2/7/2019 7:27:38 AM Applied Genetic Technologies Q2 Loss Per Share $0.23 Vs Loss $0.29 Last Year
  
 
>